Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2007 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Journal of the Brazilian Chemical Society (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532007000300009 |
Resumo: | An alternative methodology by capillary zone electrophoresis (CZE) is proposed for the determination of losartan potassium (LOS) associated with chlorthalidone (CTD) or hydrochlorothiazide (HCT) in capsules, using 50 mmol L-1 of sodium carbonate buffer with detection at 226 nm. The electrolyte system was optimized, taking into account peak profiles, resolution, run times, baseline stability and repeatability (adsorption absence). The method was successfully applied to the analysis of pharmaceutical formulations purchased in manipulation drugstores. The analytes were baseline separated in less than 5 min. The results did not present significant difference in the 95% confidence interval in relation to the label claim values. The method can be applied to analyze these compounds and could also be employed in other similar formulated products containing these drugs. |
id |
SBQ-2_8f610a4a4f312f7e20fb8df4b51d7168 |
---|---|
oai_identifier_str |
oai:scielo:S0103-50532007000300009 |
network_acronym_str |
SBQ-2 |
network_name_str |
Journal of the Brazilian Chemical Society (Online) |
repository_id_str |
|
spelling |
Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresislosartanantihypertensivediureticspharmaceutical analysiscapillary electrophoresisAn alternative methodology by capillary zone electrophoresis (CZE) is proposed for the determination of losartan potassium (LOS) associated with chlorthalidone (CTD) or hydrochlorothiazide (HCT) in capsules, using 50 mmol L-1 of sodium carbonate buffer with detection at 226 nm. The electrolyte system was optimized, taking into account peak profiles, resolution, run times, baseline stability and repeatability (adsorption absence). The method was successfully applied to the analysis of pharmaceutical formulations purchased in manipulation drugstores. The analytes were baseline separated in less than 5 min. The results did not present significant difference in the 95% confidence interval in relation to the label claim values. The method can be applied to analyze these compounds and could also be employed in other similar formulated products containing these drugs.Sociedade Brasileira de Química2007-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532007000300009Journal of the Brazilian Chemical Society v.18 n.3 2007reponame:Journal of the Brazilian Chemical Society (Online)instname:Sociedade Brasileira de Química (SBQ)instacron:SBQ10.1590/S0103-50532007000300009info:eu-repo/semantics/openAccessBalesteros,Manoela R.Faria,Adriana F.Oliveira,Marcone A. L. deeng2007-06-28T00:00:00Zoai:scielo:S0103-50532007000300009Revistahttp://jbcs.sbq.org.brONGhttps://old.scielo.br/oai/scielo-oai.php||office@jbcs.sbq.org.br1678-47900103-5053opendoar:2007-06-28T00:00Journal of the Brazilian Chemical Society (Online) - Sociedade Brasileira de Química (SBQ)false |
dc.title.none.fl_str_mv |
Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis |
title |
Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis |
spellingShingle |
Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis Balesteros,Manoela R. losartan antihypertensive diuretics pharmaceutical analysis capillary electrophoresis |
title_short |
Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis |
title_full |
Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis |
title_fullStr |
Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis |
title_full_unstemmed |
Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis |
title_sort |
Determination of losartan associated with chlorthalidone or hydrochlorothiazide in capsules by capillary zone electrophoresis |
author |
Balesteros,Manoela R. |
author_facet |
Balesteros,Manoela R. Faria,Adriana F. Oliveira,Marcone A. L. de |
author_role |
author |
author2 |
Faria,Adriana F. Oliveira,Marcone A. L. de |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Balesteros,Manoela R. Faria,Adriana F. Oliveira,Marcone A. L. de |
dc.subject.por.fl_str_mv |
losartan antihypertensive diuretics pharmaceutical analysis capillary electrophoresis |
topic |
losartan antihypertensive diuretics pharmaceutical analysis capillary electrophoresis |
description |
An alternative methodology by capillary zone electrophoresis (CZE) is proposed for the determination of losartan potassium (LOS) associated with chlorthalidone (CTD) or hydrochlorothiazide (HCT) in capsules, using 50 mmol L-1 of sodium carbonate buffer with detection at 226 nm. The electrolyte system was optimized, taking into account peak profiles, resolution, run times, baseline stability and repeatability (adsorption absence). The method was successfully applied to the analysis of pharmaceutical formulations purchased in manipulation drugstores. The analytes were baseline separated in less than 5 min. The results did not present significant difference in the 95% confidence interval in relation to the label claim values. The method can be applied to analyze these compounds and could also be employed in other similar formulated products containing these drugs. |
publishDate |
2007 |
dc.date.none.fl_str_mv |
2007-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532007000300009 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532007000300009 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S0103-50532007000300009 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Química |
publisher.none.fl_str_mv |
Sociedade Brasileira de Química |
dc.source.none.fl_str_mv |
Journal of the Brazilian Chemical Society v.18 n.3 2007 reponame:Journal of the Brazilian Chemical Society (Online) instname:Sociedade Brasileira de Química (SBQ) instacron:SBQ |
instname_str |
Sociedade Brasileira de Química (SBQ) |
instacron_str |
SBQ |
institution |
SBQ |
reponame_str |
Journal of the Brazilian Chemical Society (Online) |
collection |
Journal of the Brazilian Chemical Society (Online) |
repository.name.fl_str_mv |
Journal of the Brazilian Chemical Society (Online) - Sociedade Brasileira de Química (SBQ) |
repository.mail.fl_str_mv |
||office@jbcs.sbq.org.br |
_version_ |
1750318167849172992 |